Fangrong Yan

42PUBLICATIONS
57CO-AUTHORS
Liquid biopsiesEpidemiological methodsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Dec 10, 2025
Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Kang He, Xue-Jing Zhu, Yao-Ping Shi

|Dec 03, 2025
Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical Trials.

Jingyi Zhang, Tuo Wang, Yongming Qu

|Nov 12, 2025
SIRT5 Facilitates Liver Steatosis Progression via Promoting SDH Desuccinylation During High-Fat Diet Feeding.

Zekun Liu, Jie Hu, Yinan Lin

|Nov 05, 2025
Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Kang He, Xue-Jing Zhu, Yao-Ping Shi

|Aug 15, 2025
Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial.

Peng-Fei Jin, Ya-Ru Quan, Shi-Xin Xiu

|May 20, 2025
TODO: A Triple-Outcome Double-Criterion Optimal Design for Dose Monitoring-and-Optimization in Multi-Dose Randomized Trials.

Jingyi Zhang, Heng Zhou, Nolan A Wages

Pageof 7

Frequent Collaborators

10 joint publications

Xiaofan Lu

6 joint publications

Jialin Meng

5 joint publications

Xin Chen

4 joint publications

Ruitao Lin